Ep 3 Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study

Dr Kirk Barber speaks with Dr Jensen Yeung a dermatologist at the University of Toronto and the medical director of PERC, the Phototherapy Education and Research Centre at Women’s College Hospital in Toronto about the study he co-authored that examines the efficacy and safety of Apremilast monotherapy for moderate to severe Psoriasis. He also offers valuable insights into his use clinical use of apremilast outlining the risks and benefits from the perspective of a clinician.

Theme music: "Start of the Day" by Lee Rosevere licensed under a Creative Commons Attribution License